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Abstract
Background: Many Americans diagnosed with colon cancer do not receive indicated chemotherapy. Certain
unmarried women may be particularly disadvantaged. A 3-way interaction of the multiplicative disadvantages of
being an unmarried and inadequately insured woman living in poverty was explored.
Methods: California registry data were analyzed for 2,319 women diagnosed with stage II to IV colon cancer
between 1996 and 2000 and followed until 2014. Socioeconomic data from the 2000 census classified neighborhoods
as high poverty (≥30% of households poor), middle (5–29%) or low poverty (<5% poor). Primary health insurance was
private, Medicare, Medicaid or none. Comparisons of chemotherapy rates used standardized rate ratios (RR).
We respectively used logistic and Cox regression models to assess chemotherapy and survival.
Results: A statistically significant 3-way marital status by health insurance by poverty interaction effect on chemotherapy
receipt was observed. Chemotherapy rates did not differ between unmarried (39.0%) and married (39.7%) women who
lived in lower poverty neighborhoods and were privately insured. But unmarried women (27.3%) were 26% less likely to
receive chemotherapy than were married women (37.1%, RR = 0.74, 95% CI 0.58, 0.95) who lived in high poverty
neighborhoods and were publicly insured or uninsured. When this interaction and the main effects of health
insurance, poverty and chemotherapy were accounted for, survival did not differ by marital status.
Conclusions: The multiplicative barrier to colon cancer care that results from being inadequately insured and living in
poverty is worse for unmarried than married women. Poverty is more prevalent among unmarried women and they
have fewer assets so they are probably less able to absorb the indirect and direct, but uncovered, costs of colon cancer
care. There seem to be structural inequities related to the institutions of marriage, work and health care that particularly
disadvantage unmarried women that policy makers ought to be cognizant of as future reforms of the American health
care system are considered.
Keywords: Health insurance, Poverty, Colon cancer, Chemotherapy, Marital status, Unmarried, Women, California,
United States
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Background
Chemotherapy is often indicated for those diagnosed with
non-localized colon cancer. Survival benefits are large for
many with stage III disease and smaller, but still significant
for some with stage II disease [1-3]. In addition to its palliative benefits, there even seem to be some survival benefits of chemotherapy for people with stage IV colon cancer
[4], yet nearly half of such people in the United States
never access chemotherapy.5 Similar to health care in general, access to chemotherapy may be affected by a variety
of causes. Chemotherapy access may be affected by social
and economic characteristics such as marital status, health
insurance adequacy, income and race or ethnicity [5-8].
Because colon cancer is relatively common over the life
course, adjuvant chemotherapy matters in terms of both
survival and quality of life and such treatment access
seems sensitive to the sorts of social and policy forces
that probably determine much of America’s health inequities, chemotherapy of non-localized colon cancer
may be thought a sentinel health care quality indicator.
A 3-way ethnicity by health insurance by poverty interaction effect on chemotherapy receipt was recently observed among people with non-localized colon cancer in
California [8]. A multiplicative barrier to chemotherapy
was found suggesting that the combined effects of being
inadequately insured and living in poverty were worse
for African Americans than for non-Hispanic white
Americans. Those investigators concluded that because
African Americans are more prevalently poor, inadequately insured and have fewer assets; they are probably less able to absorb the indirect and direct, but
uncovered costs of colon cancer care. Because women,
particularly unmarried women may be similarly socioeconomically vulnerable, we wondered about the possibility of a 3-way marital status by health insurance by
poverty interaction effect on chemotherapy among them.
United States surveys have indicated that women are
much more likely to live in poverty and to be uninsured or
underinsured than are men and that being unmarried
seems to increase all such risks more for women than for
men [9,10]. Similarly surveys suggest that married women
have a higher chance of being privately insured by socalled gold or platinum health plans through employers,
regardless of whether the plan is theirs or their spouses.
Even when unmarried women can afford private health insurance, they seem to be at greatest risk of being covered
by bronze or silver plans, which typically come with high
deductible costs [11]. Seemingly more affordable because
their premiums are lower than gold or platinum plans,
their deductible costs of up to $2,500 may serve to limit
health care access, especially among lower income beneficiaries. Otherwise, unmarried women are more likely to
need to purchase additional Medicare “medigap” coverage or experience compromised Medicaid coverage with
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increasing out-of-pocket expenses. These expenses have
been predicted under the Affordable Care Act [12]. Meanwhile, gender and marital status seem associated with
colon cancer care in the United States, but the equivocally
observed care gaps have tended to be small [5,13]. We
think that this field may be limited by its focus on mere
main effects. Previous studies found complex interaction
effects of ethnicity, health insurance status and poverty on
cancer care in the United States [14-17]. For example, a
historical study of colon cancer care in California, including access to chemotherapy, concluded that poverty makes
the disadvantaging effects of being uninsured or underinsured even worse, specifically for women. This leads us
to anticipate similarly complex interactions of marital
status, health insurance and poverty among women [17].
This study explores that notion with the same Californian
cohort and advances the hypothesis that there is a 3-way
interaction of marital status, health insurance and poverty
on chemotherapy such that there is probably a multiplicative disadvantage of being an unmarried and inadequately
insured woman living in poverty.

Methods
Three thousand, three hundred women diagnosed with
colon cancer between 1996 and 2000 were randomly selected from the California Cancer Registry and joined to
the 2000 census by census tracts [17-20]. The original
sample was then stratified by socioeconomic status: high
poverty neighborhoods where 30% or more of the households were poor, mid-poverty neighborhoods where 5% to
29% were poor or low poverty neighborhoods where the
prevalence of poverty was less than 5% [21,22]. This analysis excluded localized, stage I cancers for which chemotherapy is not indicated and then analyzed colon cancer
care among 2,319 women with stage II to IV disease
[23,24]. Primary health insurers were defined as private
(included the Medicare insured with private supplemental
coverage), Medicare alone, Medicaid or none. And based
upon previous analyses in California, primary health insurance was defined as adequate (private) or inadequate
(Medicaid, Medicare or none) [16,17,25]. Marital status at
the time of diagnosis was married or unmarried (never
married or previously married).
A preliminary age, stage and grade-adjusted logistic regression model found a 4-way gender by marital status
by health insurance adequacy by poverty (lived in a high
poverty neighborhood or not) interaction effect on binary chemotherapy receipt such that the 3-way interaction was statistically significant among women, but
not men. This study’s focus is on women and statistically
tests and describes the 3-way marital status by health
insurance adequacy by poverty interaction effect on
chemotherapy among them [26]. Odds ratios (OR) and
95% confidence intervals (CI) were estimated for main
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effects from maximum likelihood regression statistics.
We tested the 3-way interaction effect by adding the
following interaction term to the regression model:
married or not × adequately insured or not × lived in a
high poverty neighborhood or not (each 0 or 1).
Married study participants were younger (M = 67.0,
SD = 13.0), on average, than unmarried participants
(M = 72.0, SD = 14.2), F (1, 4,382) = 149.48, p < .05.
Therefore, all prevalence estimates were internally ageadjusted and reported as percentages. Chemotherapy rates
were also stage-adjusted to account for variances in clinical indication and prescription rates in stages II, III and
IV of the disease. Standardized prevalence ratios (PR) or
rate ratios (RR) were reported for critical between-group
comparisons with 95% CIs derived from the MantelHaenszel χ2 test. Standardized rate differences (RD) were
also used to further aid in the interpretation of practicalclinical significance. Survival analyses used similarly adjusted Cox regression models [27]. Participants were
minimally followed for 13 years from the date of their
diagnosis until 2014. These analyses could detect rate differences of less than 5% with 80% power at a significance
level of 5% [28]. All variables except tumor grade (6.3%
missing) had less than 2% missing data, none of which
were confounding so missing data were imputed from
full regression models. Other methodological details
have been reported [17-20]. This study was reviewed
and cleared by the University of Windsor research
ethics board.

Results
Age-adjusted descriptive profiles of the married (41.7%)
and unmarried (58.3%) women with non-localized colon
cancer are displayed in Table 1. The statistically significant comparisons of socioeconomic characteristics were
congruent with existing knowledge. Unmarried women
(39.3.3%) were nearly 50% more likely than married
women (27.0%) to live in high poverty neighborhoods
(PR = 1.46, 95% CI 1.28, 1.66) and they were about 20%
more likely to be relatively inadequately insured, either
uninsured to publicly-insured (60.5% vs. 49.9%, PR = 1.21,
95% CI 1.16, 1.27). Also of interest, the two groups did
not differ significantly on the clinical-biological characteristics of disease stage or tumor grade.
As hypothesized, a statistically significant 3-way marital status by health insurance by poverty interaction was
detected with a full logistic regression on chemotherapy
receipt (bottom of Table 2). The 2-way interactions
involving marital status were also significant, but the
interaction of health insurance and poverty as well as all
of the main effects were not significant. Our interpretive emphasis will be on the, most complex, 3-way interaction. As its meaning is not necessarily intuitive, the
receipt of chemotherapy within its strata is practically
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Table 1 Demographic, socioeconomic and clinical
characteristics of married and unmarried women diagnosed
with colon cancer in California between 1996 and 2000
Married

No. (%)

Unmarried

No. (%)

*

Age at diagnosis, y
<65

388

40.1

271

20.1

65–80

458

47.3

593

43.9

>80

122

12.6

487

36.0

†

Neighborhood poverty prevalence, %
<5

391

40.3

376

27.0

5 – 29

317

32.7

458

33.7

≥30‡

260

27.0

517

39.3

50.1

482

39.5

†

Primary health insurers
Private

510

Medicare

364

41.6

732

46.4

Medicaid

44

3.9

68

7.0

Uninsured

50

4.4

69

7.1

II

409

43.5

569

40.9

III

318

32.5

417

31.5

IV

241

24.0

365

27.6

I

72

7.8

87

6.5

II

597

65.0

793

63.6

Stage at diagnosis

Tumor grade

III or IV

247

27.2

376

29.9

Missing data

52

5.4

95

7.0

Notes. Prevalence estimates (%) were directly age-adjusted using this study’s
population of women as the standard.
*
p < .05 marital group difference (χ2 test).
†
p < .05 age-adjusted marital group difference (Mantel-Haenszel χ2 test).
‡
Median annual family income for married ($23,450) and unmarried ($22,325)
subsamples of women; median test [29] χ2 (1, N = 777) = 4.12, p < .05.

depicted in Table 3. At the top of the table it can be
seen that among women who did not live in high
poverty neighborhoods and were adequately insured,
chemotherapy rates did not differ significantly between
the married (39.7%) and unmarried (39.0%). The bottom of the table suggests that among the multiply disadvantaged, women who were inadequately insured and
living in poverty, the disadvantaging effect on chemotherapy access appears multiplicative. Among them,
unmarried women (27.3%) were 26% less likely to receive chemotherapy than were married women (37.1%,
RR = 0.74, 95% CI 0.58, 0.95). This apparent multiplicative disadvantage is depicted in another way in the table’s
right column. The married-unmarried RD on chemotherapy receipt was 0.7% among the most advantaged group.
While the RD of 9.8% among the most disadvantaged
group was nearly a 15-fold multiple of that baseline difference. Such seems indicative of a large barrier to
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Table 2 Logistic regression results for main effects and
interactions of marital status, neighborhood poverty and
primary health insurers: Predictors of chemotherapy receipt
Predictors

Odds
ratio

95% Confidence
interval

Nonsignificant main effects and interactions
Unmarried

0.72

0.36, 1.44

Neighborhood poverty prevalence ≥ 30% 0.60

0.31, 1.15

Primary health insurer was private

1.06

0.59, 1.89

Neighborhood poverty by primary
health insurer

Pinteraction = .511

Significant interaction effects
Unmarried by neighborhood poverty

Pinteraction = .030

Unmarried by primary health insurer

Pinteraction = .047

Unmarried by health insurer by poverty Pinteraction = .012
Notes. All effects were adjusted for age, stage of disease at diagnosis, tumor
grade and each other. The fit of the regression model with the 3-way interaction
was significantly better than the model without it: likelihood ratio test,
χ2 (1) = 6.33, p < .05.

chemotherapy access that accounted well for betweengroup survival differences. When the main and interacting effects of chemotherapy were accounted for with
a Cox regression model survival no longer differed by
marital status (HR = 0.98, 95% CI 0.86, 1.12). Before accounting for chemotherapy unmarried women were at
significantly greater risk of dying over the follow-up
period (HR = 0.88, 95% CI 0.80, 0.98).

Discussion
We explored a 3-way marital status by health insurance
by poverty interaction effect on the receipt of chemotherapy among women with non-localized colon cancer.

More specifically, we observed an apparent multiplicative
barrier to chemotherapy of being an unmarried and inadequately insured woman living in poverty. Poverty seems
to worsen the disadvantaging effect of being inadequately
insured, especially for unmarried women. Among disadvantaged, publicly or uninsured women living in poverty,
the married-unmarried chemotherapy RD (10%) was not
only significant in a statistical sense, but could also be
characterized as practically significant. Conversely, among
relatively advantaged, privately insured women not living
in poverty, the married-unmarried chemotherapy RD was
not significant. Given the importance of chemotherapy in
the treatment of non-localized colon cancer this finding
seems of great human significance. We also found evidence that the receipt of chemotherapy can explain the
difference in survival chances between married and
unmarried women.
Two-way health insurance by poverty interactions
have previously been observed in studies of breast and
colon cancer care [8,15-17]. The beneficial effects of
health insurance were observed to be strongest in low
poverty neighborhoods. It seems that the effectiveness of
health insurance was positively impacted by the availability of other resources. In more affluent neighborhoods, where social and economic capital abounds, most
people with cancer were more able to absorb the indirect and direct, but additional uncovered, out-of-pocket
costs of cancer care. On the other hand, within high
poverty neighborhoods relatively lacking in such capital
reserves, health insurance programs were much less
effective. People who lived in such high poverty neighborhoods may have been less able to pick-up the co-insurance
costs and co-payments that are prevalent in American
cancer care delivery. The 3-way marital status-health
insurance-poverty interaction observed among women in

Table 3 Effect of the interaction of marital status, health insurance and neighborhood poverty on chemotherapy
receipt among women with stage II to IV colon cancer
No.*

Rate (%)

RR†

(95% CI)

Married-unmarried chemotherapy RD

<30% Poor & adequately insured
Married

405

39.7

1.00

...

Unmarried

344

39.0

0.98

(0.82, 1.17)

Married

408

38.3

1.00

...

Unmarried

628

34.6

0.90

(0.76, 1.07)

0.7%

Intermediate groups‡

3.7%

≥30% Poor & inadequately insured
Married

155

37.1

1.00

...

Unmarried

379

27.3

0.74

(0.58, 0.95)

9.8%

Notes. RR = standardized rate ratio, RD = standardized rate difference, CI = confidence interval. All rates were directly age and stage-adjusted using this study’s
population of women as the standard and reported as percentages (rates per 100).
*
Number of incident colon cancer cases.
†
A rate ratio of 1.00 was the baseline.
‡
Women living in high poverty neighborhoods, but adequately insured or women living in less poor neighborhoods, but inadequately insured. These two groups
did not differ significantly on their married-unmarried chemotherapy RDs.
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this study could be thought an extension of the consistently observed 2-way health insurance inadequacy-poverty
interaction. It suggests that the 2-way interaction’s disadvantaging effect is strongest for unmarried women. Their
relative lack of income and assets could explain the differential effect of marital status.
Married women have more diverse sources of income
than their unmarried or previously married peers and,
therefore, typically have greater incomes and wealth. They
also benefit from the economy of scales that attend sharing
household and other expenses with a spouse. Married
women have greater access to work-related fringe benefits,
including private health insurance, through their own or
their spouse’s employer [30,31]. We saw that even though
this study’s key comparison of unmarried and married
women was in high poverty neighborhoods, the depth of
impoverishment among the unmarried women seemed
deeper. Their annual family incomes were, typically, $1,125
less than those of married women. This difference may not
seem great, but among people with such low incomes this
represents approximately 5% of their total income. This
could make a difference, for example, in being able to absorb the indirect costs of cancer care due to time lost from
work, recuperation and transportation. It is also known
that among low-income households in America, married
women are three times more likely than unmarried women
to own a home, again representative of their relatively
greater wealth [32]. It seems that the relative lack of capital
reserves operates to further potentiate the disadvantages
already experienced by unmarried women who are inadequately insured and live in poverty.
Potential limitations

First, one may wonder about the potential confounding
influence of social supports beyond marital status. Diverse
measures of perceived social support as well as numerous
functional characteristics of social networks are well
known to be associated with diverse health care processes
and health outcomes over the life course [33]. Moreover,
social and extended familial supports seem to provide protections across all phases of cancer care, from screening
and treatment access to enhanced quality of life after
treatment and survival [34-36]. For example, friends and
extended family members might facilitate treatment access and even its success by filling such potentially important roles such as driving a friend to chemotherapy and
caring for her after chemotherapy. But the strength of
these associations as well as their interrelationships with
other of this study’s central predictors seems equivocal.
We are unaware of any consistent evidence that such
supports beyond spousal support serve to increase the
adequacy of one’s health insurance coverage. Furthermore,
we have observed that even in such extremely poor neighborhoods as Mexican American barrios where social and
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extended familial supports tend to be much greater than
in other similarly poor ethnic enclaves, the adequacy of
one’s health insurance remains a critical predictor of cancer care and survival [14,15]. Surely, social supports beyond spousal support are very important in the lives of all
people including those with cancer. But for reasons noted
above we do not think it likely that such supports fatally
confound this study’s central finding about the interaction
of marital and insurance statuses and poverty.
Second, the marital status variable that was available
for this analysis was limited in a few ways. First, its categories did not include cohabitation, that is, those who
live together as partners, who would likely share many
resources and expenses, but are not legally married.
Probably quite rare among this study’s sample of women
[37], seven of ten of whom were 65 years of age or older,
certainly some of those we classified as unmarried may
enjoy some such marriage-like benefits. Second, marital
status was only assessed at diagnosis, not accounting for
marital statuses over the life course. Many of those who
were not married at the time of their diagnosis, for example the widowed and divorced, were previously married, some for many years. Again, they may have enjoyed
some marriage-like benefits, though a wealth of research
has shown that the previously married tend to be more
similar to the never married than to the married in terms
of their economic well-being [30]. It is clear though that
both of these forms of differential misclassification bias, if
they are potent at all, would operate to cause this study to
underestimate the disadvantages of being an unmarried
woman seeking colon cancer care.
Third, because chemotherapy is most often received
as an outpatient it can be challenging for cancer registries to survey. However, we think that this study is not
potently limited by incomplete information on chemotherapy for the following reasons. First, the California
Cancer Registry is nearly complete on chemotherapy
(82–83%) and comprehensiveness has been demonstrated not to differ significantly by marital status [38].
Second, missing chemotherapy data was very modest in
this analysis and did not differ significantly between
married and unmarried samples of women. Other potential limitations have been reported [17-20]. Such potential limitations make it clear that more studies are
needed to confirm, or refute, the 3-way interaction that
this study explored.

Conclusions
Among the uninsured or underinsured living in poverty
unmarried women seemed less likely than married women
with non-localized colon cancer to receive indicated
chemotherapy. Marital status, health insurance status and
poverty appear to interact in such a way that the multiplicative barrier to care of being inadequately insured and
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poor is worst for unmarried women. They are the most inadequately insured and prevalently poor, and they hold the
fewest assets, and so, are probably the least able to absorb
the indirect and direct, but uncovered costs of colon cancer care. This suggests that there are structural inequities
related to the institutions of marriage, work and health
care that particularly disadvantage unmarried women.
Policy makers and administrators ought to be cognizant
of these factors as they consider future reforms of the
American health care system.
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